Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04711824
Title Study of Stereotactic Radiosurgery With Olaparib Followed by Durvalumab and Physician's Choice Systemic Therapy in Subjects With Breast Cancer Brain Metastases
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Colette Shen
Indications

Her2-receptor negative breast cancer

triple-receptor negative breast cancer

Therapies

Nab-paclitaxel

Cisplatin

Durvalumab + Olaparib

Paclitaxel

Capecitabine

Gemcitabine

Carboplatin

Eribulin

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.